Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Sy Jennifer, holds the title of Chief Accounting Officer at AEON Biopharma, Inc..
On 2026-11-19, the insider transacted 153,846 shares.The shares were transacted at a weighted average price of $0.13 per share, resulting in a total market-relevant value of $20K.
Sy Jennifer (Chief Accounting Officer) bought $20K of $AEON
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.